Skip to content

Oral device for treatment of obstructive sleep apnea

The effect of Mandibular Advancement Splint in comparison with Sham device on apnea hypopnea index in mild to moderate obstructive sleep apnea

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT2014071618509N1
Enrollment
50
Registered
2015-07-06
Start date
2014-12-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

obstructive sleep apnea. Sleep apnoea

Interventions

Intervention 1: Using advanced mandible splint with jaw protrusion in intervention group so that a record of jaws relation is taken while the patient is protruding lower jaw and in the next step Essix
Treatment - Devices
Placebo
placebo device (oral device without jaw protrusion) in control group
Using advanced mandible splint with jaw protrusion in intervention group so that a record of jaws relation is taken while the patient is protruding lower jaw and in the next step Essix clear device is

Sponsors

Vice Chancellor for Research, Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inclusion criteria:Age more than 18 years, Willing to participate in the study, Having mild to moderate obstructive sleep apnea (Apnea Hypopnoea Index of 5 to 30), Having enough marginal dental adaptation Exclusion criteria: Having Periodontal or other kind of oral cavity disease, Having contraindication for cephalometry (such as pregnancy), Having Advanced temporomandibular joint disease, Having contraindication for body MRI

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Apnea Hypopnea Index per hours during sleep. Timepoint: before intervention and 1 month after intervention. Method of measurement: polysomnography.

Secondary

MeasureTime frame
Oropharyngeal volumetry. Timepoint: at the beginning, with and without Mandibular Advancement Splint in interventional group. Method of measurement: Oropharyngeal MRI.;Sleep quality and daytime sleepiness. Timepoint: before intervention and 1 month after intervention in interventional and control groups. Method of measurement: sleep quality questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMahnaz Amini

Mashhad University of Medical Sciences

aminim@mums.ac.ir+98 51 3859 8818

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026